Remember When Was The Last Time A New Alzheimer's Drug Was Approved?

The development of Alzheimer's drugs has been marred by a high failure rate. Despite the high failure rate, the pharma companies have not shied away from making investments in Alzheimer's research. Let's take a look at the companies whose Alzheimer's drugs are in phase III development.

from RTT - Biotech https://ift.tt/2KpC6OB
via IFTTT